Published in Transplant Proc on December 01, 1991
The side effects of FK 506 in humans. Transplant Proc (1990) 2.08
Toxicologic evaluation of FK 506. Transplant Proc (1990) 1.36
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Kidney transplantation under FK 506. JAMA (1990) 7.45
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. Surg Res Commun (1987) 4.68
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet (1997) 2.81
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66
The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96
Role of murein lipoprotein in morphogenesis of the bacterial division septum: phenotypic similarity of lkyD and lpo mutants. J Bacteriol (1978) 1.94
Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg (2000) 1.89
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88
Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
Outcome of preimplantation genetic diagnosis of translocations. Fertil Steril (2000) 1.78
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75
Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69
EMG responses to maintain stance during multidirectional surface translations. J Neurophysiol (1998) 1.67
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
PCR primers for human chromosomes: reagents for the rapid analysis of somatic cell hybrids. Genomics (1991) 1.58
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients. Transplant Proc (1985) 1.55
Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant (2006) 1.55
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. Transplant Proc (1991) 1.40
Control of stance during lateral and anterior/posterior surface translations. IEEE Trans Rehabil Eng (1998) 1.39
Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc (1988) 1.38
Abdominal multivisceral transplantation. Transplantation (1995) 1.37
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
Effect of stance width on multidirectional postural responses. J Neurophysiol (2001) 1.28
The association of center performance evaluations and kidney transplant volume in the United States. Am J Transplant (2013) 1.28
Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies. Transplant Proc (1987) 1.25
Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol (1993) 1.23
Postural orientation, equilibrium, and the spinal cord. Adv Neurol (1997) 1.21
Adaptation of the walking pattern to uphill walking in normal and spinal-cord injured subjects. Exp Brain Res (1999) 1.20
Weight support and balance during perturbed stance in the chronic spinal cat. J Neurophysiol (1999) 1.20
Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation (1999) 1.19
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg (1992) 1.18
Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation (1994) 1.18
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Transplant Proc (1991) 1.16
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant (1994) 1.15
Primary care treatment of pediatric psychosocial problems: A study from pediatric research in office settings and ambulatory sentinel practice network. Pediatrics (2000) 1.15
Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis (2002) 1.14
Accuracy of computerized tomography in determining hepatic tumor size in patients receiving liver transplantation or resection. J Clin Oncol (1984) 1.13
Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis (1992) 1.12
Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther (2006) 1.12
Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenat Diagn (1998) 1.12
Effect of Cyclosporin-A on Hepatic and Renal Allograft Mononuclear Cell Infiltration. Transplant Proc (1983) 1.11
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. J Clin Pharmacol (1993) 1.09
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc (1990) 1.08
Cryptococcal meningitis after liver transplantation. Transplantation (1996) 1.08
Effect of different media on determination of novobiocin resistance for differentiation of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.07
Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation (2000) 1.06
Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology (1996) 1.06
Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. Transplantation (2000) 1.05
Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg (1997) 1.05
The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc (1994) 1.04
Health care concerns and guidelines for adults with Down syndrome. Am J Med Genet (1999) 1.04
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation (1990) 1.04
Persistence of extrahepatic hepatitis B virus DNA in the absence of detectable hepatic replication in patients with baboon liver transplants. J Med Virol (1995) 1.03
The role of rehabilitation in the recovery of walking in the neurological population. Curr Opin Neurol (2001) 1.03
Enteric drainage of pancreas transplants revisited. Transplant Proc (1995) 1.03
Liver resection combined with excision of vena cava. J Am Coll Surg (2000) 1.02
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg (1999) 1.02
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. Transplant Proc (1991) 1.02
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation (1996) 1.02
Carrier-specific breakpoint-spanning DNA probes: an approach to preimplantation genetic diagnosis in interphase cells. Hum Reprod (1997) 1.01
Does neurorehabilitation play a role in the recovery of walking in neurological populations? Ann N Y Acad Sci (1998) 1.00
PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant (2009) 1.00
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong. Aliment Pharmacol Ther (2006) 1.00
Stance control in the chronic spinal cat. J Neurophysiol (1994) 0.99
Spontaneous abortions are reduced after preconception diagnosis of translocations. J Assist Reprod Genet (1998) 0.99
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc (2005) 0.98
Causes of death in autopsied liver transplantation patients. Mod Pathol (1998) 0.98
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. Transplantation (1992) 0.98
Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Res Treat (1999) 0.97
Preimplantation genetic analysis of translocations: case-specific probes for interphase cell analysis. Hum Genet (1998) 0.97
Preliminary experience with FK506 in thoracic transplantation. Transplantation (1991) 0.97
Interferon-alpha-induced acute renal allograft rejection. Transplantation (1995) 0.95